Pathology and Lab Medicine - Global Oncology Academy

49-54 of 54

Recent updates from adjuvant trials in HR+/HER2- EBC
Recent updates from adjuvant trials in HR+/HER2- EBC
MinuteCE®
Recent updates from adjuvant trials in HR+/HER2- EBC
Nadia Harbeck, MD, PhD
1.25 program credits
- Nadia Harbeck, MD, PhD
1.25 program credits
Maximizing Adherence and Persistence via Patient Engagement
Maximizing Adherence and Persistence via Patient Engagement
MinuteCE®
Maximizing Adherence and Persistence via Patient Engagement
Hope S. Rugo, MD, FASCO; Nadia Harbeck, MD, PhD
1.25 program credits
- Hope S. Rugo, MD, FASCO
- Nadia Harbeck, MD, PhD
1.25 program credits
MinuteCE®
Precision Timing: Unveiling the Impact of CDK4/6 Inhibition in Early HR+/HER2- Breast Cancer
Hope S. Rugo, MD, FASCO; Nadia Harbeck, MD, PhD
1.25 credits 10 episodes
- Hope S. Rugo, MD, FASCO
- Nadia Harbeck, MD, PhD
1.25 credits 10 episodes
Expert Insights on HER2 Scoring Criteria for Breast Cancer
Expert Insights on HER2 Scoring Criteria for Breast Cancer
Project Oncology®
Expert Insights on HER2 Scoring Criteria for Breast Cancer
Jacob Sands, MD; Kathleen Fenn, MD
- Jacob Sands, MD
- Kathleen Fenn, MD
- Oudai Hassan, MD
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
Project Oncology®
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
Jacob Sands, MD; Lori Pierce, MD, FASTRO, FASCO
- Jacob Sands, MD
- Lori Pierce, MD, FASTRO, FASCO
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Clinician's Roundtable
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Ana Maria Rosario
- Ana Maria Rosario

Previous
1
2
3
4
Next

4/4